Navigating the Growing Landscape of JAK Inhibitors in Myelofibrosis
Ashwin Kishtagari, MD, discusses the treatment of patients with myelofibrosis following progression on ruxolitinib.
Source: onclive.com
Stay updated with breaking news from Bick Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ashwin Kishtagari, MD, discusses the treatment of patients with myelofibrosis following progression on ruxolitinib.